Scribd
Upload
2K views

Mitchell

Robert Mitchell application for mayor

Uploaded by

Spectrum Media
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF or read online on Scribd
2K views

Mitchell

Robert Mitchell application for mayor

Uploaded by

Spectrum Media
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF or read online on Scribd
You are on page 1/ 6
St.George Re: Application for Vacant Mayor Seat - 1 message JotForm « Reply-To: ‘To: cory.frost@sgorty.org, christina.ternandez@sgcity.org Christina Fernandez Tue, Jan §, 2021 at 6:08 PM / Application for Vacant Mayor Seat Name Robert Mitchell Mitchell Address Street Address: Phone Number Zip Coco Email Le Jam a citizen of the United States Mo Lam a registered voter inthe City of St. Yes George Ihave been a resident of the City of St George or a resident of arecently annexed Yes area of the City of St. George for the previous twelve (12) months. Ihave not been convicted of a felony Y°S Brief written statement explaining why you are mayor and any prior involvement in City or ‘community organizations or activities: 11am a product of the State of Utah but have spend most of my life, career and raised my children outside of the interested in serving as State. | have lived in California York, and several European Countries. | have lead many high-tech medical companies. In addition, | am a partner in a development project in Lake Powell, Utah where | have been exposed to the positives and negatives of government structures. | am 59, retired from operating Colorado, Indiana, New Companies, but ready to serve/give back in/to my home state. My wife and I have lived in St. George for 3 years and find it the best place on earth. We own a home in the Ledges and consider this area unmatched and plan to stay forever. |lam a seasoned leader and have been an invited key note speaker in more than a dozen countries. | have been exposed and interacted with many forms of government. | know the good and the bad including how to manage and mentor people to maximize their potential. Although | have limited political experience, | believe that my experience, understanding, work ethic very applicable for this role, | would be honored to be considered. Attach Resume and ‘written statement Mitchell CV 2020. pat documents here Applicant's Signature Date 01-05-2021 ‘You can esit this submission and view all your submissions easily, Mitchell CV 2020.paf 191k SENIOR EXECUTIVE Globally recognized leader demonstrating consistent achievement encompassing a 30+ year career leading high-tech medical device companies, identifving & building next generation technologies. Core strengths include: Executive Leadership: Strategic Planning; Team Development; International Business Acumen; Global Network; Technology Identification and Development, CAREER HIGHLIGHTS Results ortented leader and strategist with keen market understanding, ability fo resolve complex 5, build teams & develop markets. * General management success cross multiple companies, countries and cultures * Led multi-functional, multi-national teams to meet milestone and revenue targets * Led several scnior leadership teams resulting in corporate stability, profitability ahead of schedule, long term growth plans and increased shareholder value * Built complete direct, international operations from the ground up, doubled/ripled revenues + Historical and active Board Member for several humanitarian and high-tech companies + Identified, acquired and integrated new technology platforms for Cook Medical inthe vascular interventional and endovascular space including Paclitaxel Drug Elution and EVAR programs + Established Endovascular Aneurysm Sealing (EVAS) as a new category in vascular medicine + Successfully exited two venture backed startup medical device companies commercializing disruptive technologies in drug elution (NO) and for the repair of aortic aneurysms (EVARJEVAS) + Identified critical timing to engage strategie partners leading to multiple acquisition offers + Successful exits to PE and Strategie groups including Merit Medical, Arsenal, Terumo, Endologix + Recipient of several awards and recognitions + Invited lecturer and/or keynote speaker in more than a dozen countries PROFESSIONAL EXPERIENCE RDM ENTERPRISES, LLC. St. Goorge, Utah 2018 Present Founder and Chief Exceutive 2018 Present ‘Umbrella company, incomporated in 2018 to manage various holdings, investments, partnerships and board commitments (several outlined in Extracurricular Section. Interests include on-going obligations to companies helping o direct the atest generation medical technologies in various geographies including Salt Lake, St Louis, Houston, Toronto, Canada, Dublin Ireland, Monterey Mexico, Cairo Egypt and Dubai, RDM Enterprises also manages « 50% equity interest in Ticaboo Holdings Ine., 3000+ acre, expanding eal estate development project in Souther Utah (Lake Powell) inclusive of housing, hospitality denture, shops, restaurants & marine service operations, ENDOLOGIX, INC. /NELLIX, INC. Pato Alto & Irvine California, London UK 2008-2018 NASDAQ-Listed Endologix, Ine, develops manufictres, markets, and sells minimally invasive teatmens for aortic disorders, Nelli Endovascular, a Silicon Valley venture backed company, was a leading developer of innovative medical devices used by physician fr the minimally invasive weatment of Abdominal Aortic Aneurism (AAA) repair. President (Emeritus) 2018 - Present President Endologix 2011-2018 President, Chief Executive Officer, Board of Directors, Nellix 2008-2011 > $54m Transaetion with eamouts of Nellix to Endologix December 2010 > Extensive M&A activities/experience with the merger of TriVaseular in early 2016 > President, Intemational: Living in Europe, Oversce/Estabish Legal Entities, Registration, Operations, Distribution, Clinical, Regulatory, Sales and Marketing > President, Endologix: Living in Orange County California, responsible forall global Commercial, PAL, Clinical, Intemational and Compliance operations > President Emeritus: Agreement to stay engaged withthe company for internal and external ‘consulting. Help to define next generation EVAS technology. SUMMIT LIFE SCIENCES PARTNERS. Park City, Uish——_-2008- Present Co-Founder & General Partner: ‘Summit Life Sciences Partners, a Fity Million Dollar Venture Fund based in Park City Utah, specializing in early staged medical device companies. The General Partners developed strong management teams and unmatched returns by leveraging their extensive networks, experience and operational skills. Investments have Primarily been centered on early stage witha focused on Vascular, Imaging, Diagnostic and Therapeutics. ANGIODYNAMICS, INC. Queensbury, New York 22006 - 2008 AngioDynamies, a NASDAQulisted public company, isa leading provider of innovative medical devices forthe ‘minimally invasive diagnosis and treatment of cancer and peripheral vascular disease, Market cap of $300m and ‘more than 550 employees worldwide Chief Operations Officer, Executive Vice President Integration Executive, S220M RITA Medical Systems Acquisition November 2006 - April 2007 Companies number two ranked officer, reporting President & CEO > Revenues under management increased from $70M to $170M during tenure (RITA Acquisition) > Served as Central Company Leader: Directed eight Vice President/Department Heads > Served as a business partner providing leadership and consulting support to company management on ‘matters of goal setting, policy development, communication and strategie implementation in support ‘of achieving objectives and business growth, Integral in professional developments intemal and ‘extemal relations and culture building; employee recruitment and retention > Business Development Coordination M&A Direction; Developing and executing strategie policies and practices that add value tothe business, foster a climate of improvement and ensure legal and ethical compliance with federal, state and local regulations. > —Oversaw the development and administration of: reporting functions, mergers and acquisition transitioning; organizational structure and development; performance management and feedback. MILLIMED HOLDINGS, INC. Roskilde, Danmark 2004 — 2007 Millimed was established to provide innovative therapeutic solutions involving Nitrie Oxide and Advanced Tissue Management, Projects included next generation drug eluting stents, drug eluting balloons, redial sheaths, guide wires, angiographic catheters and vascular introducers, (Chairman of the Board of Directors 2006 - 2007 President & Chief Executive Officer, Board of Directors, 2004 - 2006 Millimed Holdings Inc, Millimed A/S, Millimed A/B, Blue Medical Ine. > Expanded Intellectual Property Portfolio significantly during tenure % —Solidified extemal financing 2005-06: Expanded financial runway from 3 months to 3 years, all the while maintaining equity for owners (non-diutive) > — Resiructured organization completely in 8 months: Recruited and maintained top scientific team specializing in Nitric Oxide > Reduced monthly expenditures by more than 50% during tenure % Exceeded expectations each reporting petiod, Increased productivity and focus > Served as a business partner providing central leadership and support to company management on ‘matters of goal setting, policy development, legalities, communication and strategic implementation in support of achieving objectives and business value. > Success Exit(s) during challenging financial times (Merit Medical, Blue Md, Xtent, Terumo, Arsenal) ALIGN TECHNOLOGIES Sania Ciara, California 2003 — 2004 NASDAQ-Listed Align Technology, Inc. is a medical device company that pioncered the invisible orthodontics market withthe design, manufacture and marketing of Invisalign®, the world’s leading invisible orthodontic product with over 1000 employees worldwide and revenues north of $200M during tenure. Headquartered in San Jose, California, the Invisalign product is offered in more that 45 countries and used to treat more that 1.5 milion patients. Viee President, Global Sales Executive Management Committee Board of Directors for Align Ja > > Increased Global Sales 20% during management tenure Acted as single point of contact for all corporate sales functions and initiatives, > Directed six Vice Presidents, Several Business Managers, and executives for North America, Europe, Japan, Asia Pacific and Latin American. > Key member of Executive Management Committe, reporting directly to the President and CEO. COOK MEDICAL, INC. Bloomington, indiana 1986 - 2003 World's largest privately held medical device company and first company to popularize interventional ‘medicine, pioneering many of the devices now commonly used worldwide to perform minimally invasive ‘medical procedures. The company integrates device design, biopharma, gene and cell therapy and biotech in the fields of aortic intervention; interventional cardiology; critical se medicine; gastroenterology; radiology, peripheral vascular, bone access and oncology; surgery and soft issue repair urology: and assisted reproductive technology, gynaecology and high-risk obstetrics. Senior Vice President, Global Leader for Five Strategic Business Units 1999-2003 ‘Strategic Business Unit Leader for Diagnostic & Interventional Divisions 1999 ~ 2003 Director, International Sales & Marketing 1995 — 1999 Director, Asia Pacific: Radiology & Cardiology Product Lines 1990 ~ 1995 District Manager, Radiology & Cardiology Product Lines 1986 ~ 1990 Key Executive in charge of Cooks five largest revenue generating SBU's reporting directly o the CEO versa, directed and accounted forall five Cook Incorporated Independent company functions with in excess of $1,3B, Recognized +20% revenue growth during each year of senior leadership Established and maintained essential company relationships with leading physicians, customers and lustial decision maker's worldwide. Recognized as the main company lea son, Active role and participation in overall Cook Business Development, Parinership and M&A activities, COversaw and harmonized efficiencies in manufacturing, production and product development, diving ‘essential product selection and focus Extensive international travel during tenure, spending considerable time developing emerging markets Developed life-long relationships with many Key Opinion Leaders eross multiple medical disciplines. EXTRACURRICULAR ACTIVITIES & EXPERIENCE Directorships (Chairman ofthe Board Chairman ofthe Board Chairman ofthe Board Chirman of the ‘Amecatn Holdings Ine. VESTECK Inc LOGOS Seientiic Point Zero, LLC Cairo, Egypt Philadelphia, PA Midway, Uah Highland, Utah Bostd Member Board Member ‘Board Member Hoard Member Conavi Ine Adient Technologies Summit Access Aceclerum Advisors ‘Toronto Canada Houston Texas Denver, Colorado Midway, Utah Board Member-Co Owner Boanl Member Board Member, CCO Board Member ‘Tieaboo Holdings Ine Germ Pree Earth Sei 60) Meet Ine Ledges Scientific Lake Powel, Utah Park Cty, Uh Dublin, ieland Dallas Texas Related & Former Board Member Board Member Board Member General Parner [NeoScinernational nc Jena Valve Technologies Heartlow Ine, ‘Summit Life Seienees Singapore Tnvine California Redwood California Patk City, Uiah Chairman & CEO Chairman ofthe Board Chairman ofthe Board ‘Board Member Cora Theeapentcs PULSE Therapestice _Tyche Intemational VIVOS Therapeatics Toronto Canada| St Louis, Missourt Salt Lake City, Utah Denver, Colorado Advio Board of Directors Senior Advisor Chairman, American Heat Association Westem Angio Sociely—-TVM Capital, PE ‘Aanal Heat Walk Commitee Portland Oregon Dubai UAE. Bloomington Indiana & Irvine California Chp Co-Founder and Board of Directors, Board of Directors, Member at Large Indian Society of Interventional Radiology International Society of Endovasculse Therapy’ (ISES) New Delhi India Phoenix. Arizona EDUCATION & PROFILE 1986 Bachelor of Science, Business Economics: University of Utah 2006 Masters of Business Administration: Wesleyan University (Indiana) ‘Numerous training certificates focused on management, negotiations and commercial NOTED PUBLICATIONS, ACKNOWLEDGMENTS, KEY LECTURES IVIR 1999, Volume 10, Number 8, p.428-430, Transgastric Esophageal Stent Placement (CX 2005 (BIBA) Nitric Oxide Eluting Balloon, A Novel Approach to Revascularization ISES 2009 Annual Meeting, Sac Filling Aneurysm Repair Endovascular Today, EVAR: What's Next? Jan 2009, Volume 8, No 1 IKON 2011 Annual Mecting, Novel Solutions for Endloeak Mangement 'V100, Top 100 Vesture CEO's in the Region, Pecr selected process 201] Lazard Capital, Europe Shines, Sales Grew 173%, November 2014 Asian Pacific Interventional Society, Singapore & Australia (APCCVIR) x 3 Years Dolter, Oregon Health Seicnee Center Meeting, Park City Utx 2 Years Indian Society for interventional Radiology, New Delhi India (ISVIR) Radiological Society of North America, Chicago (RSNA) x 2 Years Sovity for Cardiovascular and Interventional Radiology (SCVIR, SIR) x 3 Yeats Western Angiographic & Interventional Society, Hawaii (WAIS) x Years Bio2Device Medical Key Note Scone Valley, Mountain View, Ca Stanford Cardiovascular Technology Symposium, Palo Alto, Ca (Charing Cross Endovascular meeting, London England (CX) x 7 Years, >20 Lectures, VEITH Symposium, New York City, x 4 Years, >10 Lectures Israel Vascular Society, Tel Aviv Israel, Key Note Speaker British Society of Endovascular Therapy, Key Note Speaker, Walton Warwickshire, UK Society of Aneurysm Sealing, Key Note Speaker, London UK, 2 Years Power of Choice LIVE Symposium, Key Note Speaker, Warsaw Poland Asian Pacific meeting for SIR, Key Note Speaker, Auckland New Zealand Key Note Speaker for Hong Kong annual vascular meeting Invited lecturer during Poland Vascular Society Meeting, 2 Years

You might also like

pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy